Introduction
============

Rett syndrome (RTT) is a progressive neurodevelopmental disorder. It primarily affects females, who show the first obvious symptoms within 6--18 months after birth. Among the characteristics are a regression of mental and physical development as well as severe disabilities such as breathing disturbances, loss of speech, autistic features, cognitive impairment, and epilepsy ([@B51]; [@B32]; [@B11]). In the majority of cases, RTT is caused by spontaneous mutations in the X-chromosomal *MECP2* gene encoding for the transcriptional regulator MeCP2 ([@B1]).

Patient and rodent studies confirm that mitochondria are morphologically and functionally affected in RTT ([@B25]; [@B6]; [@B30]; [@B29]; [@B49]; [@B63]; [@B59]). Human skeletal muscle and frontal lobe biopsy samples revealed swollen mitochondria with vacuolizations and granular inclusions ([@B56]; [@B25]; [@B14]). In male Rett mice carrying a knockout mutation of the *Mecp2* gene (*Mecp2^-/y^* mice), we previously observed that hippocampal mitochondria show less negative membrane potentials and increased FAD/NADH baseline-ratios, which indicates an intensified degree of oxidation and increased levels of ROS ([@B30]; [@B46]). Also, brain ATP content is affected. Higher resting ATP levels with increased ATP turnover rates were reported for neonatal hippocampal *Mecp2^-/y^* neurons ([@B62]), whereas whole brain studies on adult symptomatic male and female Rett mice detected reduced ATP concentrations ([@B57]; [@B18]; [@B64]).

In view of these findings, also specific changes in mitochondrial respiration are to be expected. The mitochondrial respiratory chain consists of four complexes, CI, CII, CIII, and CIV, which are transporting electrons from reducing equivalents (NADH+H^+^, FADH~2~) to molecular oxygen. This electron transport extrudes protons across the inner membrane, and the resulting membrane potential then drives ATP synthesis by the F~1~F~o~-ATP synthase (CV) ([@B44]). Indeed, Rett patients show lower expression levels of cytochrome *c* oxidase subunit I as well as reduced enzymatic activities of cytochrome *c* oxidase and succinate cytochrome *c* reductase ([@B13]; [@B28]). Also in Rett mice, lowered enzymatic activities of the respiratory complexes are evident in brain and skeletal muscle ([@B38]; [@B29]; [@B18]; [@B64]). In concert with altered O~2~ consumption rates ([@B38]) these changes may easily culminate in reduced brain ATP contents ([@B57]; [@B18]; [@B64]).

Nevertheless, detailed information on the very brain regions affected and on the exact time course of mitochondrial changes in RTT is sparse. Another issue still to be addressed, is whether besides differential protein levels and activities also altered protein/protein interactions may contribute to the mitochondrial dysfunction in RTT. The mitochondrial respiratory chain forms large supercomplexes in which CI binds to a dimer of CIII and several copies of CIV ([@B58]; [@B39]; [@B74]). This supercomplex formation guarantees an efficient energy transduction within the respiratory chain, prevents energy leakage, and dampens ROS production. Pathological changes in supercomplex structure were reported for many disease models ([@B68]; [@B20]; [@B48]; [@B23]) -- but at present it is unclear whether this may be the case also in RTT.

Another aspect is that mitochondria are a prominent source of ROS. During electron transport from CI to CIV approximately 2--5% of electrons escape and diffuse directly to O~2~, thereby generating superoxide ([@B8]; [@B65]; [@B9]). Hence, the increased mitochondrial activity and ATP turnover in Rett mice ([@B38]; [@B30]; [@B62]) should be associated with increased ROS generation. Indeed, an intensified H~2~O~2~ production was observed in isolated mitochondria of female Rett mouse brains ([@B18]; [@B64]). It appears to contribute to the systemic oxidative burden and the oxidative tissue damage in RTT ([@B15]; [@B16]), which is assumed to drive the disease progression in RTT ([@B17]; [@B30]; [@B46]; [@B45]). Yet again, these studies were performed on full brain and do not provide any brain region-specific or even subcellular insights. Furthermore, it still has to be clarified in detail, how the mitochondrial alterations are mechanistically linked to redox-imbalance, oxidative stress, and neuronal network dysfunction in RTT.

Therefore, we took a closer look at redox balance specifically in neurons, and we quantified redox conditions in their cytosolic and mitochondrial compartment, by using the advanced, genetically encoded redox sensor roGFP1. Furthermore, we assessed multiple aspects of mitochondrial physiology in defined brain regions of Rett mice to unravel the interplay of mitochondrial alterations and cellular redox balance in this neurodevelopmental disorder. In particular, we focused on hippocampal and cortical tissue, as these brain areas are metabolically highly demanding, very vulnerable to oxidative stress, and essentially underlie complex cognitive functions. By means of quantitative redox imaging and comprehensive biochemical protein analyzes, we confirm that the redox impairment in RTT affects neuronal cytosol as well as mitochondrial matrix. Only moderate decreases in the expression of respiratory complex constituents were evident in mitochondria of *Mecp2^-/y^* hippocampus and cortex. Nevertheless, their O~2~ consumption rate was increased in the presence of CII substrates. Also, an intensified ROS generation was confirmed for mitochondria of *Mecp2^-/y^* hippocampus and cortex.

Materials and Methods {#s1}
=====================

As a mouse model for RTT, we chose *Mecp2* knockout mice \[B6.129P2(C)-*Mecp2^tm1.1Bird^*\] ([@B31]). In order to ensure uniform conditions, i.e., a total lack of MeCP2 in each single cell studied by our cell-based and tissue analyzes, only male Rett mice (*Mecp2^-/y^*) were used. They develop symptoms earlier, present a more severe phenotype, and were compared with their male WT siblings. Optimized breeding of Rett mice could be achieved with WT (NMRI line) foster mice only, which took better care of the offspring than the female Rett mice (*Mecp2^+/-^*). All experiments were in accordance with German regulations and authorized by the Office of Animal Welfare of the University Medical Center Göttingen as well as by the Lower Saxony State Office for Consumer Protection and Food Safety. Mouse genotypes were disclosed only after data collection and analysis. Yet, for *Mecp2^-/y^* mice, the genotype eventually became obvious due to their characteristic phenotype and behavior.

Solutions
---------

Unless stated differently, all chemicals were obtained from Sigma-Aldrich. Growth medium used for organotypic slice cultures consisted of minimum essential medium (MEM, Invitrogen) supplemented with 5% FCS, 0.5 mM L-glutamine, 20 μl/ml B27 50× supplement (Invitrogen), 2 μM cytosine arabinoside, and 100 μg/ml penicillin-streptomycin (Biochrom). ACSF contained 130 mM NaCl, 3.5 mM KCl, 1.25 mM NaH~2~PO~4~, 24 mM NaHCO~3~, 1.2 mM CaCl~2~, 1.2 mM MgSO~4~ and 10 mM dextrose, and was aerated constantly with 95% O~2~ plus 5% CO~2~ (carbogen) to ensure a stable pH of 7.4 as well as a proper O~2~ supply of the tissue under investigation. The redox stimulants H~2~O~2~ (30% aqueous stock solution), DEDTC, and 1,4-dithio-DL threitol (DTT, Fluka) were added to the ACSF immediately before use. AMC was first dissolved as 20 mM stock solution in absolute ethanol and stored at -20°C. The oxidation-sensitive dyes H~2~DCFDA (2′,7′-dichlorodihydrofluorescein diacetate, Invitrogen) and Amplex UltraRed (Invitrogen) were dissolved in dimethyl sulfoxide as 100 mM and 10 mM stock solutions, respectively, and stored at -20°C.

Hippocampal Slice Cultures
--------------------------

Organotypic slice cultures were prepared from neonatal male mice at PD 3--5, as described earlier ([@B61]; [@B30]). After decapitation, the brain was removed and placed in ice-cold Hanks' balanced salt solution. Isolated hippocampi were cut into 350 μm-thick slices (McIlwain tissue chopper, Stoelting Co.), placed on the membranes of six-well culture plates (Transwell Permeable Support, Corning), and incubated under interface conditions at 37°C in a 5% CO~2~-atmosphere. Each well contained 1 ml growth medium, half of which was replaced every 2--3 days.

Optical Recordings and Transduction Procedures
----------------------------------------------

Cellular redox conditions were monitored with a CCD-camera imaging system. It was controlled by TILLvisION 4.0.1 software (TILL Photonics) and consisted of a xenon light source (Polychrome II; Till Photonics), a sensitive CCD camera (Imago QE; PCO Imaging), and an upright fluorescence microscope (Axioskop I; Zeiss) with a 63× 1.0 NA water immersion objective (Plan-Apochromat; Zeiss). For the imaging experiments, slice cultures were placed with their support membranes in a submersion-style chamber and superfused with pre-warmed ACSF (37°C, 4.5 ml/min).

Neuronal redox balance was quantified with the excitation-ratiometric optical redox sensor roGFP1 ([@B21]; [@B33]). This optical probe does not detect a particular reactive oxygen or nitrogen species, but rather reports thiol redox balance, and it responds reversibly to redox modulation. Hence, roGFP1 senses -- similar to numerous other cellular proteins ([@B71]) -- the subcellular thiol redox conditions. In detail, oxidation increases light absorption at 390 nm and decreases absorption at 470 nm; reduction causes opposite responses. Therefore, we excited roGFP1 alternatingly at 395 and 470 nm, and calculated the resulting fluorescence ratio R ([@B27]; [@B30]); as optical filters we chose a 460--480 nm bandpass excitation filter, a 495 nm dichroic mirror, and a 525--550 nm bandpass emission filter. Among the advantages of this excitation-ratiometric approach are highly stable recordings as well as improved response dynamics, and the ratiometric redox responses obtained are independent of the expression level of the redox sensor. Nevertheless, quantitative analyses demand that those roGFP1 ratios are determined which correspond to full oxidation (R~ox~) and full reduction (R~red~), as induced by saturating doses of H~2~O~2~ (5 mM), and DTT (10 mM), respectively ([@B33]; [@B27]; [@B67]). Once calibrated, the relative degree of oxidation OxD~roGFP1~ can be determined for the respective experimental conditions \[see ([@B43])\]:
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Based on OxD~roGFP1~ and the standard redox potential of roGFP1 (E^0^′ = -291 mV), the Nernst equation then yields the corresponding roGFP1 redox potentials ([@B33]; [@B43]; [@B67]):
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After confirming reliable responses of roGFP1 in hippocampal cells and slices ([@B27]; [@B30]), we developed viral constructs (AAV6) and placed roGFP1 under the human synapsin 1 promoter, to optimize the transduction efficiency and to ensure a neuron-specific expression. Without further targeting sequences, roGFP1 is expressed in the cytosol (cyto-roGFP1). Its reliable expression in mitochondrial matrix (mito-roGFP1) is guaranteed by the included mitochondrial targeting sequence of subunit VIII of cytochrome *c* oxidase ([@B10]). Slice cultures were transduced on DIV 3--4, by applying 2.5 μl of the vector (1:50 dilution in PBS; undiluted titer 1.3 × 10^8^ particles/μl) onto each slice. Redox imaging experiments were then performed between DIV 9--15.

Tissue Preparation From Adult Mice
----------------------------------

Adult male mice (PD43-49) were ether anesthetized, decapitated, and the brain removed as described earlier ([@B26]). The heart was isolated as well, and the collected tissue was processed further to prepare mitochondrial suspensions. Excess tissue was cryopreserved in liquid N~2~ and stored at -80°C for later use.

Mitochondrial Suspensions
-------------------------

Mitochondrial isolation was performed as described before, with some modifications ([@B2]). The rigid cardiac tissue was first sliced into small pieces, transferred into 1 ml isolation buffer and minced in a blender (Ultra Thurax T8, IKA Labortechnik). Hippocampal and cortical tissue was transferred into isolation buffer (20 mM HEPES pH 7.6, 220 mM mannitol, 70 mM sucrose, 1 mM 2,2′,2′′,2′′′-(1,2-ethanediyldinitrilo)-tetraacetic acid (EDTA), 0.5 mM PMSF, and homogenized (Potter S, Sartorius) at 1 × 300, 1 × 500, and 25 × 700 rpm. After removing cell debris by centrifugation (800 g, 15 min, 4°C) supernatants were pooled and centrifuged again for 30 min to remove remaining debris. Part of the supernatant was cryopreserved as whole-cell lysate for later protein analyzes. Remaining supernatant was centrifuged at 10,000 g (10 min, 4°C) to spin down the mitochondrial fraction, and the pellets were resuspended in isolation buffer. Final volume and protein amounts were determined by Bradford assay.

Protein Analysis
----------------

Proteins of whole cellular lysates were separated by SDS-PAGE (12.5% SDS-PAGE), loading 10--20 μg/lane protein. Blue native (BN) gel electrophoresis was performed as reported earlier ([@B72]; [@B66]). For Western blot analysis 30 μg/lane of isolated mitochondria were used. In-gel activity staining required higher protein amounts (CI: 50 μg/lane, CIV: 100 μg/lane, and CV: 150 μg/lane). Mitochondrial membranes were solubilized in lysis buffer \[20 mM Tris/HCl pH7.4, 0.1 mM EDTA, 50 mM NaCl, 10% (v/v) glycerol, 1% (w/v) digitonin, 1 mM PMSF\] and incubated for 30 min at 4°C while shaking constantly. Non-solubilized material was removed by centrifugation (Eppendorf 5415R, 16,000 g, 5 min, 4°C). Supernatants were transferred into a new sample tube and mixed with 10× loading buffer \[5% (w/v) Coomassie Brilliant Blue G-250, 500 mM 𝜀-amino-n-caproic acid diluted in 100 mM Bis-Tris pH7.0\]. Samples were separated on a 4--14% poly-acrylamide gradient gel, using a cathode buffer (50 mM Tricine pH7.0, 15 mM Bis-Tris, 0.02% Coomassie G-250) and an anode buffer (50 mM Bis-Tris/HCl pH7.0) ([@B19]).

For Western blots, standard methods were used to transfer proteins to polyvinylidene fluoride membranes. After blocking (5% skimmed milk diluted in TBS containing 0.1% Tween), membranes were probed with primary antibodies. Anti-NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 (NDUFB8), anti-succinate dehydrogenase A (SDHA, Cell Signaling Technology), anti-ubiquinol-cytochrome *c* reductase, Rieske iron-sulfur polypeptide 1 (Rieske), anti-cytochrome *c* oxidase subunit I (COX1), ATP synthase subunit beta (AtpB, Antikoerper-online), and anti-VDAC3 were produced in rabbit. Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 5G4-6C5, Biotrend) was produced in mice. Secondary antibodies were coupled to horseradish peroxidase (Dianova). Chemiluminescence (ECL^TM^ Western blot detection reagent, GE or Clarity^TM^ Western ECL substrate, BioRad) was detected using films (Medix XBU Medical X-Ray Film, Foma Bohemia) or imaged with a camera (Image Reader LAS-1000, Fujifilm). Signal intensities were analyzed by Aida Image Analyzer V.3.10.

In-gel catalytic activity of native respiratory chain complexes separated by BN-PAGE was rated as reported earlier ([@B75]; [@B73]). CI activity was visualized with 2.5 mg/ml NTB in staining solution (0.1 mg/ml NADH and 5 mM Tris, pH 7.4) at 37°C until staining became visible. For CIV staining, cytochrome *c*, reduced with 15 mg/ml Na-dithionite, was added at a concentration of 1 mg/ml to the staining solution containing 0.5 mg/ml diaminobenzidine in 50 mM KPi, pH 7.4. CV staining was performed in 35 mM Tris--HCl pH 8.3, 270 mM glycine, 14 mM MgSO~4~ 0.2% Pb(NO~3~)~2~, and 8 mM ATP. Band intensities were quantified by ImageQuant TL 1D Version 7.0 (GE Health Care).

Mitochondrial O~2~ Consumption
------------------------------

For quantitative analysis of O~2~ consumption, a Seahorse XF96 Extracellular Flux Analyzer (Seahorse Bioscience) was used. Isolated mitochondria were resuspended in assay buffer (MAS, 70 mM sucrose, 220 mM mannitol, 2 mM HEPES, 10 mM KH~2~PO~4~, 5 mM MgCl~2~, 1 mM EGTA, and 0.2% BSA, pH 7.4), and loaded to a 96-well sample plate. A centrifugation step (2,000 g, 20 min, 4°C, Allegra X-15R, Beckman Coulter) ensured that mitochondria adhered to the bottom of the wells. Basal respiration was measured at 37°C, in 180 μl MAS containing 2 mM malate + 10 mM pyruvate or 4 mM succinate as substrate. Subsequent consecutive measurements were performed after reoxygenation and automated administration of 12 mM ADP, 1.5 μM oligomycin, 4 μM FCCP, and 4 μM antimycin A + 2 μM rotenone. Data were analyzed with the XF96 Software (Version 1.3.0.79).

ROS Formation by Isolated Mitochondria
--------------------------------------

Mitochondrial ROS formation was probed with the oxidation-sensitive dyes H~2~DCFDA (100 μM) and Amplex UltraRed (10 μM). These cuvette assays are standard approaches, which define ROS formation in response to mitochondrial challenges and/or in transgenic mouse models ([@B41]; [@B53]). In the case of AmplexRed, H~2~O~2~ is detected in a coupled reaction with horseradish peroxidase (1 U/ml) ([@B76]; [@B37]). Isolated mitochondria (40 μg) were resuspended in MAS buffer for native conditions or in a denaturing buffer (20 mM Tris, 150 mM NaCl, 0.1% Triton, pH 7.4). The oxidation of H~2~DCFDA and Amplex UltraRed is irreversible. Accordingly, accumulation of the oxidized dye results in a continuous increase in fluorescence emission. For H~2~DCFDA it was monitored with a fluorescence spectrophotometer (Hitachi F-7000) at 495 nm excitation and 525 nm emission wavelengths, and for Amplex UltraRed a multimode spectrophotometer (flx-Xenius XM, SAFAS Monaco) with 555 nm excitation and 581 nm emission wavelengths was used.

Body Temperature Measurements
-----------------------------

The core body temperature of mice was determined with a rectal probe (MLT451) and a temperature controller (TC1000, ADInstruments) on three consecutive days. The first day served to adapt the mice to the procedure; the temperatures measured on the second and third day were averaged for each mouse.

Statistics
----------

Throughout the manuscript, data are presented as mean ± standard deviation. For each diagram it is indicated whether the number of experiments (*n*) equals the number of cells analyzed (optical imaging) or the number of mice studied (biochemical assays, tissue samples). Significance of the differences observed was determined by unpaired two tailed student's *t*-test. Genotype-related differences are marked by asterisks (^∗∗∗^*p* \< 0.001, ^∗∗^*p* \< 0.01, ^∗^*p* \< 0.05) and genotype-matched differences among cell compartments are identified by crosshatches (^\#\#\#^*p* \< 0.001, ^\#\#^*p* \< 0.01, ^\#^*p* \< 0.05). In the case of normalized data, a one-sample *t*-test served to compare the observed changes to control conditions (defined as unity, i.e., 1.0 or 100%) ([@B4]).

Results
=======

Redox Balance in Mitochondrial Matrix and Cytosol
-------------------------------------------------

Our previous analyses revealed a cytosolic redox-imbalance in *Mecp2^-/y^* hippocampus ([@B30]). To compare in detail the redox conditions in mitochondria and cytosol of *Mecp2^-/y^* neurons in organotypic hippocampal slice cultures, we analyzed the resting-baseline (steady-state) redox conditions in both cell compartments, and recorded also their dynamic responses to various acute redox-stimuli. For these tasks, we used our recently established viral constructs. They express roGFP1 under the control of the synapsin 1 promoter, mediating a neuron specific expression, and proper subcellular targeting to either cytosol (cyto-roGFP1) or mitochondrial matrix (mito-roGFP1) ([@B10]). RoGFP1 enables quantitative analyses of subcellular redox conditions, but this requires detailed response calibrations for each cell-compartment. Therefore, with saturating doses of H~2~O~2~ (5 mM) and DTT (10 mM) we defined those ratiometric values which correspond to full roGFP1 oxidation and reduction, respectively ([Figure 1A](#F1){ref-type="fig"}). H~2~O~2~ (7 min) increased the mito-roGFP1 ratio to 1.52 ± 0.16, and DTT decreased it to 0.68 ± 0.02 (*n* = 12, [Figure 1B](#F1){ref-type="fig"}). As cyto-roGFP1 responded more promptly, the redox-stimulants were applied for 5 min only, but very similar calibration values were obtained as in mitochondria (*n* = 20; [Figure 1B](#F1){ref-type="fig"}).

![Reduction-oxidation sensitive green fluorescent protein 1 (roGFP1) response calibration reveals genotypic and compartmental redox differences at baseline resting conditions. **(A)** Dynamic response of cyto-roGFP1 to saturating oxidation and reduction, as recorded from a WT slice culture. **(B)** The box plot summarizes the response ranges of mito-roGFP1 and cyto-roGFP1 determined during the calibration experiments. The bottom of each box represents the fully reduced state evoked by 10 mM DTT, the ceiling indicates the fully oxidized level induced by 5 mM H~2~O~2~. Error bars in this and all other figures are standard deviations; the number of cells analyzed is reported for each bar. The similarity of the determined response ranges confirms that roGFP reliably functions in both, cytosol and mitochondrial matrix. **(C)** OxD~roGFP1~ confirms more oxidized baseline conditions in the cytosol of *Mecp2^-/y^* hippocampal neurons than in WT neurons. Mitochondrial redox baselines did not differ among genotypes. Statistically significant differences between WT and *Mecp2^-/y^* neurons are indicated by asterisks (^∗∗∗^*p* \< 0.001). Genotype-matched differences among mitochondria and cytosol are indicated by crosshatches (^\#\#\#^p \< 0.001). Pairwise comparisons were run as unpaired two-tailed *t*-tests; the number of cells studied is included in each bar. **(D)** These genotypic and compartmental redox differences are also evident from the calculated roGFP1 reduction potentials (E~roGFP1~; ^\#\#^*p* \< 0.01).](fphys-10-00479-g001){#F1}

Based on these calibrations, the relative degrees of roGFP1 oxidation (OxD~roGFP1~) and E~roGFP1~ were calculated for steady-state resting baseline conditions. To define genotype-related differences, the respective cell compartments were compared among WT and *Mecp2^-/y^* slices. Furthermore, to identify subcellular, i.e., compartment-specific differences in a given genotype, cytosol and mitochondrial matrix were compared to each other. This revealed that in WT neurons, mitochondrial matrix was more oxidized than their cytosol. Yet, mitochondrial redox baselines did not differ among WT and *Mecp2^-/y^* slices. In contrast, cytosolic redox balance was more oxidized in *Mecp2^-/y^* than in WT neurons ([Figure 1C](#F1){ref-type="fig"}). As a result, the cytosol of *Mecp2^-/y^* neurons was even more oxidized than their mitochondria. These compartmental and genotypic differences are also reflected by the E~roGFP1~ ([Figure 1D](#F1){ref-type="fig"}).

Next, we assessed the dynamic redox responses of both cell compartments to defined challenges. As irregular respiration with intermittent hypoxia is a hallmark of RTT, the effect of O~2~ shortage was determined. O~2~ withdrawal (N~2~/CO~2~-aerated ACSF, 10 min), evoked a reducing shift in roGFP1 ratio, which was more intense in *Mecp2^-/y^* mitochondria and *Mecp2^-/y^* cytosol than in the WT compartments ([Figure 2A,E,F](#F2){ref-type="fig"}). Oxidant challenge was induced by low-dose H~2~O~2~ or by inhibition of the scavenging enzyme SOD1 (Cu/Zn SOD). H~2~O~2~ (200 μM, 3--5 min) elicited an oxidizing shift in roGFP1 ratio, which was more pronounced in *Mecp2^-/y^* than in WT mitochondria, but did not differ among *Mecp2^-/y^*, and WT cytosol ([Figure 2B,E,F](#F2){ref-type="fig"}). Blocking SOD1 by DEDTC ([@B34]; [@B24]) (5 mM, 5 min) induced an oxidation of roGFP1, which was consistently more pronounced in WT mitochondria and cytosol than in the respective *Mecp2^-/y^* compartments ([Figure 2C,E,F](#F2){ref-type="fig"}). Mitochondrial impairment was mimicked by the CIII-blocker AMC (20 μM, 10 min), and it evoked a slow oxidizing shift, which was more intense in *Mecp2^-/y^* mitochondria and cytosol as compared to the WT compartments ([Figure 2D--F](#F2){ref-type="fig"}).

![Acute redox challenge uncovers a more fragile redox homeostasis in mitochondrial matrix and cytosol of *Mecp2^-/y^* hippocampal neurons. **(A)** As revealed by the imaging of subcellular redox dynamics, O~2~ withdrawal evoked a reducing shift in the cytosolic roGFP1 fluorescence ratio, which was more intense in *Mecp2^-/y^* neurons. Time scaling also applies to the following traces. **(B)** Low-dose H~2~O~2~ induced a more pronounced oxidation in *Mecp2^-/y^* mitochondria. **(C)** The cytosol of *Mecp2^-/y^* neurons responded less intensely to DEDTC, a blocker of SOD1. **(D)** Block of CIII by AMC elicited a more pronounced oxidation in *Mecp2^-/y^* mitochondria. **(E)** Summary of the redox alterations in mitochondrial matrix. Plotted are changes in mito-roGFP1 ratio and in the mito-roGFP1 reduction potential. Asterisks indicate statistically significant differences as compared to WT in unpaired two-tailed *t*-tests (^∗∗∗^*p* \< 0.001, ^∗∗^*p* \< 0.01, ^∗^*p* \< 0.05). The number of cells studied is reported for each bar. **(F)** Summarized redox responses of the cytosolic compartment (cyto-roGFP1).](fphys-10-00479-g002){#F2}

Mitochondrial Mass and Expression Levels of Respiratory Complexes
-----------------------------------------------------------------

An increased cellular density of mitochondria may be a potential cause of the oxidative burden in RTT. Therefore, we asked whether mitochondrial mass differs in WT and *Mecp2^-/y^* mice. As mitochondrial marker we chose VDAC3, an integral membrane protein of the outer mitochondrial membrane; the cytosolic protein GAPDH served as loading control. Clear cellular lysates of hippocampus, cortex and heart (*n* = 5 each genotype) were separated by SDS-PAGE, and both proteins detected in the same sample by Western blot analysis ([Figure 3A](#F3){ref-type="fig"}). Normalizing the expression of VDAC3 to GAPDH, did not reveal any differences in mitochondrial mass of adult *Mecp2^-/y^* hippocampus or cortex as compared to WT. Only a trend toward increased mitochondrial mass was evident in *Mecp2^-/y^* heart, which did, however, not reach the level of significance (*p* = 0.101; [Figure 3B](#F3){ref-type="fig"}).

![Mitochondrial mass is not altered in *Mecp2^-/y^* hippocampus and cortex. **(A)** In Western blot analyses, VDAC3 served as mitochondrial marker. Its expression was referred to GAPDH, and tissue lysates of hippocampus, cortex, and heart were compared among WT and *Mecp2^-/y^* siblings. Dashed line indicates the membrane cut after protein blotting. **(B)** In densitometric analyzes genotypic differences for hippocampus and cortex were not found. Mitochondrial mass tended to be higher though in *Mecp2^-/y^* heart (*n* = 5 mice each). Plotted VDAC3/GAPDH ratios are normalized to WT conditions (defined as unity, see dashed line), statistical significance was assessed by one-sample *t*-tests.](fphys-10-00479-g003){#F3}

As a reduced enzymatic activity of key mitochondrial functions is evident in RTT ([@B13]; [@B38]; [@B28]; [@B29]; [@B18]; [@B64]), we analyzed steady state levels of constituents of the mitochondrial respiratory chain. Tissue lysates were separated by SDS-PAGE and protein levels of core constituents of the respiratory chain were analyzed by Western blotting ([Figure 4A](#F4){ref-type="fig"}). All complexes were detectable in the WT and *Mecp2^-/y^* samples, but normalization to GAPDH content did not reveal any genotypic differences in the protein levels of CII, CIII, and CIV ([Figure 4B](#F4){ref-type="fig"}). In *Mecp2^-/y^* hippocampus and cortex, however, CI protein levels (NDUFB8) were slightly lower than in WT. Furthermore, ATP-synthase (CV, ATP5B) was slightly less expressed in *Mecp2^-/y^* cortex ([Figure 4B](#F4){ref-type="fig"}).

![Protein expression levels of NDUFB8 and ATP5B differ only slightly between *Mecp2^-/y^* and WT mice. **(A)** Protein lysates were separated by SDS gel electrophoresis and analyzed by Western blotting, using antibodies specific against NDUFB8 (CI), SDHA (CII), Rieske (CIII), COX5A (CIV), ATP5B (CV), and GAPDH. Dashed lines indicate the membrane cut after protein blotting. The displayed blots of CII and CIII are from the same experiment and therefore share a common loading control; this also applies to CV and CI. **(B)** Expression levels of the proteins of interest were quantified by densitometry, normalized to GAPDH within the same tissue sample and then referred to the WT samples (defined as unity, see dashed line). The number of samples (mice) analyzed is reported; asterisks mark statistically significant differences as compared to WT in one sample *t*-tests (^∗^*p* \< 0.05).](fphys-10-00479-g004){#F4}

Structure of Mitochondrial Respiratory Chain Complexes
------------------------------------------------------

Structural changes of the mitochondrial respiratory chain may provoke the generation of ROS ([@B12]; [@B66]). As roGFP1 imaging revealed exaggerated redox shifts of *Mecp2^-/y^* mitochondria in response to hypoxia and AMC, we screened for potential structural changes of the mitochondrial respiratory chain. We isolated mitochondria from hippocampus, cortex, and heart by differential centrifugation of tissue lysates ([@B2]; [@B23]) and solubilized the isolated mitochondria in the mild detergent digitonin to preserve the supercomplex association. Solubilized protein complexes were then separated by native gel electrophoresis (BN-PAGE) and detected using antibodies against the core component of the complexes. CI was exclusively integrated in supercomplexes and the CI + CIII complex, which was visualized using antibodies against the CI subunit NDUFB8 in the high molecular range of the native gel. CIII and CIV were detected clearly in supercomplexes but were also present as smaller complexes ([Figure 5A](#F5){ref-type="fig"}). ATPase was found in two complexes representing the monomeric V~M~ and the dimeric form V~D~. Obvious differences in the supercomplex-assembly among WT and *Mecp2^-/y^* tissues were not identified.

![Pathological remodeling of the respiratory chain supercomplexes in mitochondria of *Mecp2^-/y^* mice is not evident. **(A)** Isolated mitochondria were solubilized in digitonin, separated by native gel electrophoresis (BN-PAGE), and respiratory chain complexes were analyzed by Western blotting. Due to limited space, *Mecp2^-/y^* tissue is denoted here as "*-/y"*. **(B)** Respiratory chain complexes were separated by BN-PAGE and stained for enzymatic activity of CI, CIV, and CV. Marked alterations for the respective respiratory complexes were not found. The section of the gel flanked by the dashed lines was analyzed in more detail in panel **C**. **(C)** Quantitative analysis of CI activity staining by densitometry does not reveal marked genotypic differences among WT and *Mecp2^-/y^* hippocampus. Dashed line indicates WT conditions, the number of samples (mice) analyzed is indicated (^∗^*p* \> 0.05, one sample *t*-test).](fphys-10-00479-g005){#F5}

Therefore, we next analyzed the activity of the respiratory chain. The complexes were separated by BN-PAGE and subsequently their enzymatic activity visualized by in-gel activity staining. This method allows a direct correlation of their enzymatic activity with their position on the BN-PAGE gel. Specific staining for CI, CIV, and ATP synthase activity corresponded well with their positions in Western blot analyses, confirming specificity of the chosen antibodies ([Figure 4](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}). Activity staining showed most intense signals for heart, which also corresponds well to stronger signals in the Western blot approach ([Figure 5B](#F5){ref-type="fig"}). Also for brain, prominent CI signals were obtained consistently. As CI showed a well distinguishable pattern, the individual bands (750, 850, 900, and 950 kDa) were specifically analyzed by densitometry and normalized to the respective WT pattern; pronounced differences were, however, not found ([Figure 5C](#F5){ref-type="fig"}). Hence, despite detailed analyses of brain and heart tissues, the in-gel activities of CI, CIV, and CV did not markedly differ among WT and *Mecp2^-/y^* mice.

Mitochondrial O~2~ Consumption Rates
------------------------------------

Potential defects of the energy transmission in between complexes of the respiratory chain can be assessed only by quantifying the consumption of molecular oxygen. Isolated mitochondria from hippocampus, cortex and heart of WT, and *Mecp2^-/y^* mice therefore underwent real-time respirometry ([Figure 6A](#F6){ref-type="fig"}). Mitochondrial suspensions were supplied with CI substrates (2 mM malate, 10 mM pyruvate) to define the O~2~ consumption rate of basal respiration. Adding ADP (12 mM) then markedly increased O~2~ consumption (state 3 respiration) to a similar extent in WT and *Mecp2^-/y^* samples ([Figure 6A](#F6){ref-type="fig"}). Subsequent inhibition of ATP synthase (1.5 μM oligomycin) largely diminished O~2~ consumption in all samples, but did not reveal any genotype-related differences. FCCP application (4 μM) then evoked the maximal uncoupler-stimulated respiratory state, again, without revealing genotypic differences. Finally, mitochondrial respiration was blocked by AMC (4 μM) plus rotenone (2 μM), which almost completely abolished O~2~ consumption. The remaining fraction of residual O~2~ consumption did not differ either among *Mecp2^-/y^* and WT samples.

![Intensified O~2~ consumption by mitochondria of *Mecp2^-/y^* brain in the presence of CII substrates. **(A)** O~2~ consumption rates of isolated mitochondria were measured at basal conditions in the presence of CI substrates. Subsequent measurements were performed after administration of ADP, the uncoupler FCCP and AMC plus rotenone. Neither basal respiration nor the other respiration states differed among WT and *Mecp2^-/y^* tissues. The number of samples (mice) analyzed is shown in the legend of each plot. **(B)** In the presence of ADP and the CII substrate succinate, O~2~ consumption was increased in *Mecp2^-/y^* hippocampal and cortical mitochondria as compared to WT (^∗∗∗^*p* \< 0.001, unpaired two-tailed *t*-test). In heart, no changes were found. **(C)** Rotenone abolished the genotypic differences, suggesting that reverse electron flow from succinate into CI contributes to the increased O~2~ consumption of mitochondria from *Mecp2^-/y^* hippocampus and cortex. **(D)** The rotenone effect is especially clear, when the mitochondrial O~2~ consumption rates of *Mecp2^-/y^* samples are normalized to the respective WT conditions (^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001; one sample *t*-tests).](fphys-10-00479-g006){#F6}

Recently, a dysfunction of CII was reported for female Rett mice ([@B18]). Therefore, we quantified mitochondrial O~2~ consumption also in the presence of the CII substrate succinate (4 mM). Indeed, respiration after addition of ADP (10 mM) was increased in *Mecp2^-/y^* hippocampus and cortex as compared to WT samples ([Figure 6B](#F6){ref-type="fig"}). In heart, this genotypic difference was not evident. As reverse electron flux through complex I is one of the major mechanisms of mitochondrial ROS production ([@B42]; [@B22]), we included rotenone (10 μM) into the assay buffer. Under these conditions, which prevent a reverse electron transport from succinate, the increased O~2~ consumption rates in *Mecp2^-/y^* cortex and hippocampus were no longer evident ([Figure 6C](#F6){ref-type="fig"}). This is in particular evident, when the normalized respiration rates (*Mecp2^-/y^* referred to WT) are plotted ([Figure 6D](#F6){ref-type="fig"}).

Mitochondrial ROS Production
----------------------------

To assess whether the altered mitochondrial activities in *Mecp2^-/y^* hippocampus and cortex may give rise to an increased oxidative burden, we monitored the ROS generation of mitochondrial suspensions in a spectrofluorometric assay with the oxidation-sensitive dyes H~2~DCFDA and Amplex UltraRed. The extent and time course of dye oxidation depend on the amount of ROS generated, and were compared for isolated mitochondria from adult WT and *Mecp2^-/y^* brains. As both dyes may be prone to photo- and auto-oxidation, we also analyzed control cuvettes containing buffer plus dye but no mitochondria. Monitoring H~2~DCFDA fluorescence over 20 minutes showed a pronounced oxidation only in the native mitochondria-containing samples and a more intense ROS formation by *Mecp2^-/y^* mitochondria ([Figure 7A](#F7){ref-type="fig"}). In contrast, in denaturing buffer (Triton X-100), we did not observe a marked oxidation of H~2~DCFDA nor any genotypic differences, confirming their dependence on native mitochondria with fully functional respiratory complexes as well as intact mitochondrial membranes ([Figure 7B](#F7){ref-type="fig"}). For verification, we ran this assay also for native mitochondria in the presence of CI plus CII substrates (2 mM malate, 10 mM pyruvate, 4 mM succinate), and again observed a more intense ROS formation in *Mecp2^-/y^* than in WT hippocampal and cortical mitochondria ([Figure 7C](#F7){ref-type="fig"}). For further confirmation, mitochondrial ROS formation was then rated also with the more reliable reagent Amplex UltraRed. This again verified a more intense ROS generation in native, energized mitochondria from *Mecp2^-/y^* hippocampus and cortex ([Figure 7C](#F7){ref-type="fig"}).

![Increased ROS release from mitochondria of *Mecp2^-/y^* hippocampus and cortex. **(A)** ROS generation was quantified in mitochondrial suspensions under native conditions (assay buffer without substrates) using the oxidation-sensitive dye H~2~DCFDA. Genotypic comparison reveals an increased ROS formation by mitochondria from *Mecp2^-/y^* hippocampus. The control cuvettes (Ctl) contain buffer plus dye only and report the extent of photo- and autoxidation of H~2~DCFDA during the course of this assay. **(B)** In contrast, under denaturing conditions, neither a pronounced oxidation of H~2~DCFDA nor a genotypic difference among WT and *Mecp2^-/y^* hippocampus was observed. This confirms that it is indeed the native mitochondria, which mediate the marked oxidation of H~2~DCFDA in this cuvette assay. **(C)** Also with the substrates malate, pyruvate, and succinate included into the assay buffer, mitochondria from *Mecp2^-/y^* hippocampus (HC) and cortex (CTX) released higher amounts of ROS than WT mitochondria (dashed line). This was confirmed unequivocally also with the more reliable reagent Amplex UltraRed. For comparison of the different conditions tested, the normalized fluorescence ratios are plotted, by referring *Mecp2^-/y^* responses to the respective WT conditions. The number of samples (mice) analyzed is reported; asterisks mark statistically significant differences as compared to WT (one sample *t*-tests; ^∗^*p* \< 0.05, ^∗∗∗^*p* \< 0.001).](fphys-10-00479-g007){#F7}

Body Temperature Measurements
-----------------------------

Intensified mitochondrial metabolism may result in an increased body temperature, as part of the energy resting in the proton gradient may be converted into heat by regulated uncoupling ([@B47]; [@B52]). Therefore, we measured the core body temperatures of WT and *Mecp2^-/y^* mice (∼PD50). On average, WT males had a body temperature of 37.4 ± 0.6°C (*n* = 11), whereas it was lower in *Mecp2^-/y^* males (35.7 ± 1.1°C, *n* = 12). Hence, a direct effect of the detected mitochondrial alterations on body temperature can be excluded, and the lower temperature of *Mecp2^-/y^* mice is likely a consequence of their markedly reduced body weights (WT 21.5 ± 1.2 g; *Mecp2^-/y^* 12.4 ± 2.1 g).

Discussion
==========

In the present study we quantified subcellular redox changes in hippocampal neurons, and assessed molecular changes of the individual respiratory complexes, their enzymatic activities, and their O~2~ consumption rates in brain and heart tissue. For these analyzes it was essential to ensure a complete lack of MeCP2 in each single cell being studied. Therefore, the heterozygous condition in female *Mecp2^+/-^* mice -- which would have resulted in a mixed population of cells expressing and lacking MeCP2 -- was circumvented by running all experiments on tissue isolated from male mice. Of course, RTT affects mostly females, but here disease mechanisms were studied on the (sub)cellular level. For a later *in vivo* assessment of redox-balance based therapies, it would of course be essential to include also female mice in the experiments, as only they truthfully represent the clinically relevant heterozygous condition.

Redox Conditions in Mitochondrial Matrix and Cytosol
----------------------------------------------------

Subcellular redox conditions were imaged using the genetically encoded roGFP1 sensor ([@B21]; [@B33]). Whereas our previous studies still relied on lipofection ([@B30]; [@B5]), we now took advantage of our recently developed viral constructs ([@B10]), to assure a highly neuron-specific expression of roGFP1. With this marked improvement, we specifically addressed redox balance in neurons of *Mecp2^-/y^* hippocampus, and obtained for the very first time a functional readout of redox conditions in living MeCP2-deficient cells at subcellular resolution. Clear compartmental differences became apparent. In WT neurons, mitochondria were more oxidized than the cytosol, which corresponds to smooth muscle ([@B70]), and our findings in excitatory hippocampal neurons of adult redox-indicator mice ([@B67]). Furthermore, in *Mecp2^-/y^* neurons, the cytosol was more oxidized than in WT, and it was even more oxidized than the mitochondrial matrix of *Mecp2^-/y^* neurons. In RTT, it therefore seems to be especially the cytosolic compartment, which is affected by an impaired and more oxidized redox balance.

In mitochondrial matrix, genotypic differences in redox resting baseline levels were not obvious. Nevertheless, mitochondria may challenge cytosolic redox balance by releasing oxidants. Superoxide is generated especially at CI and CIII ([@B8]; [@B65]; [@B9]) and it accumulates not only in the matrix but also in the intermembrane space ([@B9]), from where it then may reach the cytosol. Indeed, earlier studies on isolated full brain and cerebellar mitochondria demonstrated by homovanillic acid/horseradish peroxidase-based spectrophotometric assays that mitochondria of female Rett mice generate larger amounts of H~2~O~2~ than those of WT mice ([@B18]; [@B64]).

In line with these reports we observed a more intense oxidation of H~2~DCFDA and Amplex UltraRed by native *Mecp2^-/y^* hippocampal and cortical mitochondria. Despite being a common approach, H~2~DCFDA-assays need to be interpreted carefully, especially when applied in complex systems such as isolated tissues or intact cells. In contrast to Amplex UltraRed, H~2~DCFDA is not specific for H~2~O~2~ but responds also to hydroxyl radicals, peroxynitrite, and carbonate anion radicals. Furthermore, it may be oxidized by heme proteins or via Fenton chemistry by transition metals, and the enzymatic deacetylation of H~2~DCFDA as well as the oxidation of H~2~DCF may intrinsically generate ROS ([@B55]; [@B7]; [@B69]; [@B36]). Therefore, we conducted the H~2~DCFDA assay in the simplified preparation of isolated mitochondria under native as well as denatured conditions and included respective controls.

In mitochondria-free buffers, an only slight oxidation of H~2~DCFDA occurred, ruling out transition metal contaminations of assay solutions or pronounced autoxidation. In denatured mitochondria (Triton-X100) a partial oxidation of H~2~DCFDA but no genotypic differences were seen. Therefore, some transition metal- or heme protein-mediated oxidation of H~2~DCFDA may have occurred in a genotype-independent manner. As most intense H~2~DCFDA oxidation and clear genotypic differences were evident in native mitochondria only, they can be assumed to depend largely on an intact inner mitochondrial membrane, a functional respiratory chain and mitochondrial membrane potential, and hence the ROS-formation inherent to mitochondrial (patho)physiology. Quantification or identification of the very oxidants involved is of course not possible with this assay for the above mentioned problems; also the obtained oxidation rates might be overestimated in view of the autocatalytic nature of the fluorescence dye used. For unequivocal confirmation, we therefore ran the Amplex UltradRed assay which specifically detects H~2~O~2~ ([@B76]; [@B37]), and verified a more intense H~2~O~2~ release for native *Mecp2^-/y^* hippocampal and cortical mitochondria. In view of genotype-related differences, it therefore can be concluded that isolated native *Mecp2^-/y^* hippocampal and cortical mitochondria mediate a higher oxidative burden than WT mitochondria, which also includes the release of intensified amounts of ROS.

In addition to the differing steady-state redox baselines, acute redox challenges confirmed also a less stable redox homeostasis in *Mecp2^-/y^* cytosol and mitochondria. Blocking of CIII elicited more intense oxidizing responses in *Mecp2^-/y^* cytosol and mitochondria. Upon O~2~ withdrawal, both compartments showed more pronounced reducing shifts than those in WT neurons. In contrast, inhibiting SOD1 evoked less intense oxidations in *Mecp2^-/y^* cytosol and mitochondria than in WTs, which matches the dampened SOD1 activity found in RTT patient blood samples ([@B60]). The cerebral redox-imbalance in RTT is, however, not limited to neurons. Just recently, we found the cytosol of *Mecp2^-/y^* hippocampal astrocytes to be more oxidized than in WTs ([@B5]).

The roGFP1 redox sensor contains exposed thiols, which adjust to ambient redox conditions. Therefore, it does not detect a particular oxidant, but rather reports general thiol redox balance, and it behaves as other cell-endogenous redox-sensitive proteins, which are controlled by redox-sensing thiols ([@B33]; [@B43]). Such redox regulation of protein function/activity was estimated to affect \>800 (human) proteins ([@B71]). Accordingly, the redox imbalance in cytosol and mitochondria of *Mecp2^-/y^* hippocampus may tremendously disturb protein function via either too reducing or too oxidizing conditions. This would already suffice to provoke neuronal dysfunction and distort neuronal network properties, long before oxidative tissue damage occurs.

Mitochondrial Mass and Protein Expression Levels
------------------------------------------------

A crucial aspect, in which our mitochondrial assays differ from most earlier studies is that no sample pooling or full brain analyzes were performed. Instead, to detect subtle differences among *Mecp2^-/y^* and WT mice, we analyzed defined brain samples of individual mice. Also, we included heart tissue to assess mitochondrial function in another organ as well. Nevertheless, it is important to recall that even isolated from specified tissues of individual mice, mitochondrial suspensions derive from mixed cell populations, i.e., various neurons and glial cells in the case of brain samples.

Our Western blot analyses on hippocampus and cortex did not indicate any changes in mitochondrial mass. This is in line with MeCP2-deficient mouse fibroblasts and *MECP2* mutant human embryonic stem cells differentiated into neurons ([@B40]; [@B59]). Yet, we saw a trend toward increased mitochondrial mass in *Mecp2^-/y^* heart, and cell culture studies found higher mitochondrial contents in microglia ([@B35]) and hippocampal astrocytes of juvenile Rett mice ([@B5]). In part, an increased mitochondrial mass may serve to compensate the mitochondrial underperformance in RTT. However, this seems to be cell- and tissue-specific, and limited to certain developmental stages or experimental preparations. It certainly cannot explain in general the redox imbalance in RTT.

Rett mouse brains and patient-derived tissues present a heterogeneous spectrum of mitochondrial alterations ([@B46]; [@B63]; [@B59]). Seemingly contradictory results arose especially from gene-arrays. An overall upregulation of the subunits of various respiratory complexes was found in blood (lymphomonocytes) of RTT patients ([@B50]), whereas a genome-wide transcriptional repression, including various mitochondrial proteins, was evident in an embryonic stem cell model of RTT ([@B40]). This emphasizes the importance of standardized procedures and the need of analyzing not only differential transcription, but also final protein levels. Fact is that despite potential candidate genes, details on actual changes in mitochondrial protein expression are still sparse. In late symptomatic male Rett mice, a downregulation of CI was seen in full brain mitochondria ([@B38]), and a lower expression of CIV was found in skeletal muscle ([@B29]). More recent whole brain studies on female MeCP2-308 mice did not reveal any obvious alterations of the individual mitochondrial complexes ([@B18]; [@B64]). Instead, alterations were region specific, affecting the striatum in which CI and CIII showed lowered protein expression levels ([@B18]).

This regional specificity corroborates our results from symptomatic *Mecp2^-/y^* mice. CI (NDUFB8) was slightly less expressed in *Mecp2^-/y^* hippocampus and cortex than in WT, and CV (ATP5B) was slightly less expressed in *Mecp2^-/y^* cortex. Interesting in view of the CII-related intensified O~2~ consumption in *Mecp2^-/y^* hippocampus and cortex may be the trend toward an increased CII expression (SDHA) in these areas. Evidence for a lowered expression of CIV, as reported for *post mortem* frontal cortex of patients ([@B28]), was not found in our mouse samples. Interestingly, in heart tissue no genotypic differences in the expression of the respiratory complexes were detected.

Functionality and Stability of Respiratory Supercomplexes
---------------------------------------------------------

The intensified mitochondrial ROS generation in Rett mice and the associated oxidative stress could aggravate mitochondrial dysfunction by destabilizing individual subunits of the supercomplex, abolishing facilitated electron channeling and releasing further ROS. However, steady state protein levels of the core components of the respiratory chain did not reveal noticeable changes. Neither were any obvious genotypic differences in the organization or enzymatic activity of mitochondrial supercomplexes detected in hippocampus, cortex and heart. Thus, a structural remodeling of the highly energy efficient supramolecular assemblies cannot be a cause for the limited mitochondrial performance in RTT.

This does not rule out, however, that the altered metabolic rate of isolated mitochondria may arise from a differential expression or altered enzymatic activities of some smaller regulatory subunits of these supercomplexes. Along this line, protein kinase A-dependent phosphorylation of CI (NDUFS4), which controls respiratory capacity and mitochondrial ROS formation, is decreased in the cerebellum of female Rett mice ([@B18]). Also elevated expression of the adenine nucleotide transporter 1 (ANT1) was proposed to cause an enhanced basal H^+^ leak of the inner mitochondrial membrane, followed by a compensatory increase of mitochondrial respiration ([@B59]).

In-gel activity staining revealed no obvious genotype-specific defects in the enzymatic activities of CI, CIV, and CV. This suggests that at least in hippocampus, cortex and heart of *Mecp2^-/y^* mice, enzymatic activities of mitochondrial complexes are mostly intact. In line with this is also the unaltered ATP content we detected in the hippocampus of symptomatic *Mecp2^-/y^* mice ([@B26]). Earlier studies on full brains mostly found reduced mitochondrial activities. Heterozygous female Rett mice (MeCP2-308) show lower CII and CV enzyme activities ([@B18]), whereas in *Mecp2^+/-^* mice CI, CII, and CV are less active ([@B64]). In contrast, for *Mecp2^-/y^* mice a reduced CIV activity and an enhanced CIII activity were reported ([@B38]). Also skeletal muscle analyses revealed dampened enzyme activities of CII, CIII, and CIV in male MeCP2-deficient mice ([@B29]). Similarly, in patient muscle, succinate cytochrome *c* reductase (CII--CIII) and CIV activities are diminished ([@B13]). Analyzing cardiac muscle, we did not detect any changes in the enzyme activities of the respiratory complexes.

Mitochondrial O~2~ Consumption Rates
------------------------------------

Quantifying mitochondrial O~2~ consumption revealed no changes for *Mecp2^-/y^* heart, but increased rates for *Mecp2^-/y^* hippocampus and cortex fueled by CII substrates. This genotypic difference vanished in the presence of rotenone, which suggests that reverse electron flow into CI may be a contributing factor. As CII is not integrated structurally into the respiratory chain supercomplexes, we did not expect to observe any corresponding structural differences in the native gel electrophoresis. Others determined the O~2~ consumption rates of mitochondria from whole *Mecp2^-/y^* brain with polarographic O~2~ electrodes, and observed elevated rates for all respiration states ([@B38]). Also in *Mecp2^-/y^* microglia the O~2~ consumption is increased ([@B35]). In female Rett mice (MeCP2-308), increased respiratory rates were found in full brain-derived mitochondria fueled by complex II substrates ([@B18]; [@B64]), indicating that mitochondrial defects also extend to the milder heterozygous genotype. In contrast, *MECP2* mutant human neurons, derived from stem cells, showed a lower basal O~2~ consumption, and reduced maximal respiration rate ([@B40]), but these data were normalized to cell count and not to protein content.

As the observed reverse electron flow into CI may provoke maximal mitochondrial ROS production -- especially with succinate as substrate ([@B65]) -- this may well explain the more oxidized redox balance in *Mecp2^-/y^* hippocampal neurons, and similar conditions can be expected for cortical neurons. Others report intensified H~2~O~2~ formation by isolated brain mitochondria ([@B18]; [@B64]) and elevated oxidative stress markers in blood, muscle and brain of Rett mice ([@B16]; [@B29]).

A potential impact of the detected redox- and metabolic alterations on mitochondrial morphology remains to be elucidated. Our current focus was on functional aspects; nevertheless, this structural/functional interaction may be of interest as the RTT--related alterations in mitochondrial function may not necessarily be accompanied by gross alterations in their morphology ([@B38]).

Conclusion
==========

Our study confirms by quantitative subcellular redox imaging that the redox imbalance in RTT affects neurons and involves their cytosol and mitochondria. Major changes in the expression and enzyme activity of the respiratory complexes were not found, and a dissociation of mitochondrial supercomplexes was ruled out. Accordingly, massive mitochondrial defects and/or marked dysfunction of entire respiratory complexes can be excluded, which matches the observation that a pronounced neurodegeneration does not occur in RTT ([@B3]). Instead, only moderate alterations in mitochondrial function and/or mitochondrial regulation are to be expected, which may result in an inefficient electron flow within the respiratory chain, but do not threaten cellular viability. In line with this concept, mitochondria from *Mecp2^-/y^* hippocampus and cortex consumed more O~2~. This confirms the earlier proposed intensified mitochondrial respiration rates ([@B38]; [@B30]) and supports the concept that the mitochondrial underperformance in RTT may be considered an *"energy wasting state"* with increased O~2~ consumption but lowered ATP production ([@B35]). In view of these changes and the increased mitochondria mediated oxidative stress and ROS formation detected by us and others ([@B18]; [@B64]), a causal chain appears more than likely. It spans from increased mitochondrial activity and O~2~ consumption, over exaggerated mitochondrial ROS release and cytosolic/mitochondrial redox imbalance to disturbed neuronal network function and a facilitation of disease progression.

Interestingly, alterations in mitochondrial morphology and metabolism with closely associated oxidative stress have also been confirmed for autism-spectrum disorders, Down syndrome and fragile X syndrome, which suggests that these alterations may be common to a broad array of genetic disorders with are closely associated with intellectual disabilities \[see: ([@B54]; [@B63])\]. Hence, a chain of common disease mechanisms may have to be considered, which emphasizes the importance of clarifying the detailed interrelation of mitochondrial alterations, redox imbalance and symptom severity.

In human neuroblastoma cells, a direct causal link of MeCP2 availability and mitochondrial function was proven by MeCP2 knockdown, which resulted in a diminished cytochrome *c* oxidase activity ([@B28]). Accordingly, a therapeutic targeting of mitochondria appears promising. Indeed treating female Rett mice with the serotonin receptor 7 agonist LP-211 or the bacterial protein CNF1 (cytotoxic necrotizing factor 1) improved mitochondrial function and dampened their ROS production ([@B18]; [@B64]). Therefore, it will be crucial now to define in detail the exact time course of mitochondrial impairment as well as the particular brain areas affected by these alterations and the downstream redox-imbalance. Only then, it will be possible to assess and judge reliably the potential merits of mitochondria- and redox-directed treatments in RTT.
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